Annual revenue:
N/ASummary
- RGLS annual revenue is not available.
Performance
RGLS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Quarterly revenue:
N/ASummary
- RGLS quarterly revenue is not available.
Performance
RGLS Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM revenue:
N/ASummary
- RGLS TTM revenue is not available.
Performance
RGLS TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
RGLS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
RGLS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
RGLS Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $10.01M(+46.5%) | $5.00M(0.0%) | $10.01M(+99.2%) |
| Sep 2020 | - | $5.00M(>+9900.0%) | $5.02M(+8273.3%) |
| Mar 2020 | - | $6000.00(-66.7%) | $60.00K(-99.1%) |
| Dec 2019 | $6.83M(+9388.9%) | $18.00K(0.0%) | $6.83M(0.0%) |
| Sep 2019 | - | $18.00K(0.0%) | $6.83M(0.0%) |
| Jun 2019 | - | $18.00K(-99.7%) | $6.83M(0.0%) |
| Mar 2019 | - | $6.78M(>+9900.0%) | $6.83M(+9388.9%) |
| Dec 2018 | $72.00K(0.0%) | $18.00K(0.0%) | $72.00K(0.0%) |
| Sep 2018 | - | $18.00K(0.0%) | $72.00K(0.0%) |
| Jun 2018 | - | $18.00K(0.0%) | $72.00K(0.0%) |
| Mar 2018 | - | $18.00K(0.0%) | $72.00K(0.0%) |
| Dec 2017 | $72.00K(-94.0%) | $18.00K(0.0%) | $72.00K(0.0%) |
| Sep 2017 | - | $18.00K(0.0%) | $72.00K(-72.1%) |
| Jun 2017 | - | $18.00K(0.0%) | $258.00K(-64.3%) |
| Mar 2017 | - | $18.00K(0.0%) | $723.00K(-39.4%) |
| Dec 2016 | $1.19M(-94.2%) | $18.00K(-91.2%) | $1.19M(-90.1%) |
| Sep 2016 | - | $204.00K(-57.8%) | $12.04M(-12.1%) |
| Jun 2016 | - | $483.00K(-1.2%) | $13.70M(-19.7%) |
| Mar 2016 | - | $489.00K(-95.5%) | $17.05M(-17.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $20.76M(+170.7%) | $10.86M(+482.3%) | $20.76M(+47.0%) |
| Sep 2015 | - | $1.86M(-51.4%) | $14.12M(+5.9%) |
| Jun 2015 | - | $3.83M(-8.7%) | $13.34M(+30.3%) |
| Mar 2015 | - | $4.20M(-0.5%) | $10.24M(+33.5%) |
| Dec 2014 | $7.67M(-60.8%) | $4.22M(+289.6%) | $7.67M(-13.9%) |
| Sep 2014 | - | $1.08M(+47.1%) | $8.90M(-36.1%) |
| Jun 2014 | - | $736.00K(-54.9%) | $13.94M(-22.4%) |
| Mar 2014 | - | $1.63M(-70.1%) | $17.96M(-8.2%) |
| Dec 2013 | $19.57M(+54.1%) | $5.45M(-10.9%) | $19.57M(+12.8%) |
| Sep 2013 | - | $6.12M(+28.6%) | $17.35M(+23.6%) |
| Jun 2013 | - | $4.76M(+47.0%) | $14.04M(+11.5%) |
| Mar 2013 | - | $3.24M(0.0%) | $12.59M(-0.8%) |
| Dec 2012 | $12.70M(-7.9%) | $3.24M(+15.3%) | $12.70M(-1.0%) |
| Sep 2012 | - | $2.81M(-15.1%) | $12.82M(-7.2%) |
| Jun 2012 | - | $3.31M(-1.0%) | $13.82M(+31.5%) |
| Mar 2012 | - | $3.34M(-0.6%) | $10.52M(+46.6%) |
| Dec 2011 | $13.79M(+60.3%) | $3.36M(-11.7%) | $7.17M(+88.3%) |
| Sep 2011 | - | $3.81M | $3.81M |
| Dec 2010 | $8.60M | - | - |
FAQ
- What is the all time high annual revenue for Regulus Therapeutics?
- What is the all time high quarterly revenue for Regulus Therapeutics?
- What is the all time high TTM revenue for Regulus Therapeutics?
What is the all time high annual revenue for Regulus Therapeutics?
Regulus Therapeutics all-time high annual revenue is $20.76M
What is the all time high quarterly revenue for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly revenue is $10.86M
What is the all time high TTM revenue for Regulus Therapeutics?
Regulus Therapeutics all-time high TTM revenue is $20.76M